Correlation between sonoVue enhancement in CEUS, HCC differentiation and HCC diameter: Analysis of 130 patients with hepatocellular carcinoma (HCC)

Ultraschall in der Medizin

Volumn 30, Issue 6, 2009, Pages 544-550

  Von Herbay, A ^a   Vogt, C ^b   Westendorff, J ^a   Haussinger D ^b   Gregor, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Abdomen; Contrast agents; Ultrasound

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SIZE; CELL DIFFERENTIATION; CONTRAST ENHANCEMENT; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; TUMOR VASCULARIZATION;

AGED; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE;

EID: 72049088265     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-0028-1109745     Document Type: Article

References (31)

1. Qauia E, Degobbis F, Tona G, et al. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol Med 2004 107 155-165
2. Jang H J., Kim T K., Burns P N., et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: Comparison with histologic differentiation. Radiology 2007 244 898-906
3. Herbay A von, Vogt C, Willers R, et al. Real-time imaging with the sonographic contrast agent SonoVue: Differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004 23 1557-1568 (Pubitemid 39586861)
4. Strobel, Seitz K, Blank W. Contrast-enhanced ultrasound for the characterization of focal liver lesions diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall in Med 2008 29 499-505
5. Strobel D, Kleinecke C, Hansler J, et al. Contrast-enhanced sonography for the characterisation of hepatiocellular carcinomas-correlation with histological differentiation. Ultraschall in Med 2005 26 270-276
6. Ding H D., Wang W P., Huang B J. Imaging of focal liver lesions: low mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 2005 24 285-297
7. Herbay A von, Vogt C, Häussinger D. Late-phase pulse-inversion sonography using the contrast agent Levovist: differentiation between benign and malignant focal lesions of the liver. Am J Roentgenol 2002 179 1273-1279 (Pubitemid 35204386)
8. Herbay A von, Vogt C, Häussinger D. Pulse-inversion-sonography in the early phase of the ultrasound contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med 2002 21 1191-1200 (Pubitemid 35257566)
9. Herbay A von, Vogt C, Häussinger D. Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent Levovist. J Ultrasound Med 2004 23 207-215
10. Albrecht T, Hoffmann C W., Schettler S. A., et al. Phase-inversion sonography during the liver-specific late phase of contrast-enhancement: improved detection of liver metastases. Am J Roentgenol 2001 176 1191-1198
11. Dörffel Y, Wermke W. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography. Ultraschall in Med 2008 29 506-514
12. Herbay A von, Häussinger D, Gregor M, et al. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and levovist (SH U 508 A) comparison of SonoVue and Levovist in HCC. Ultraschall in Med 2007 28 168-175
13. Dietrich C F., Ignee A, Trojan J, et al. Improved characterisation of histologically proven liver tumors by contrast enhanced ultrasonography during the portal venous and specific late phase of SH U 508 A. Gut 2004 53 401-405
14. Herbay A von, Donner A, Jung G, et al. Contrast-enhanced-sonography of the liver is important for planning of the therapeutical strategy in hepatocellular carcinoma. Med Klin 2004 99 89-92
15. Nicolau C, Catalá V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004 14 1092-1099
16. Torzilli G, Olivari N, Moroni E, et al. Contrast-enhanced intraoperative ultrasonography in surgery for hepatocellular carcinoma in cirrhosis. Liver Transplantation 2004 10 (2 Suppl 1) S34-S38
17. Solbiati L, Tonollini M, Cova L, et al. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 2001 11 E15-E26
18. Numata K, Tanaka K, Kiba T, et al. Contrast-enhanced, wide-band harmonic gray-scale imaging of hepatocellular carcinoma. J Ultrasound Med 2001 20 89-98
19. Rickes S, Schulze S, Neye H, et al. Improved diagnosing of small carcinomas by echo-enhanced power Doppler sonography in patients with cirrhosis. Eur J Gastroenterol & Hepatol 2003 15 881-883
20. Honda H, Tajima T, Tagucji K, et al. Recent developments in imaging diagnostics for HCC: CT arteriography and CT arterioportography evaluation of vascular changes in premalignant hepatic nodules. J Hepatobiliary Pancreat Surg 2000 7 245-251
21. Amano S, Ebara M, Yajima T, et al. Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 2003 18 273-279
22. Noguchi Y, Murakami T, Kim T, et al. Detection of hepatocellular carcinoma: comparison of dynamic MR-imaging with dynamic double arterial phase helical CT. Am J Roentgenol 2003 180 455-460 (Pubitemid 36135031)
23. Zhou L, Rui J A., Ye D X., et al. Edmondson-Steiner grading increases the predictive efficiency of TNM staging für long-term survival of patients with hepatocellular carcinoma after curative resection. World J Surrg 2008 32 1748-1756
24. Hirohashi S, Ishak K G., Kojiro M, et al. Hepatocellular carcinoma. Hamilton SR, Aaltonen LA World health classification of tumours. Pathology and genetics of tumours of the digestive system Lyon IARC 159-172
25. Edmondson H A., Steiner P E. Primary carcinoma of the liver. A study of 100 cases among 48 900 autopsies. Cancer 1954 7 462-503
26. Konopke R, Kersting S, Saeger H D., et al. Detection of liver lesions by contrast-enhanced ultrasound-comparison to intraoperative findings. Ultraschall in Med 2005 26 107-113
27. Fan Z H., Chen M H., Dai Y. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. Am J Roentgenol 2006 186 1512-1519
28. Cosgrove D, Blomley M. Liver tumors: evaluation with contrast-enhanced ultrasound. Abdom Imaging 2004 29 446-454
29. Dietrich C F. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol 2004 51 S9-S17
30. Honda H, Tajima T, Kajiyama K, et al. Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings. Am J Roentgenol 1999 173 1213-1217
31. Craig J R., Peters R L., Edmondson H A., et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and clinico-pathologic features. Cancer 1980 46 372-379